Cargando…
Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
Mortality associated with cannabis used for treatment of epilepsy is not well documented. We discuss two fatalities in the setting of epilepsy and self-determined therapy with cannabis (SDTC). One patient had probable sudden unexpected death in epilepsy, the second death was due to seizure-associate...
Autores principales: | Kollmyer, Devon M., Wright, Kyla E., Warner, Nicole M., Doherty, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348695/ https://www.ncbi.nlm.nih.gov/pubmed/30705819 http://dx.doi.org/10.1016/j.ebcr.2018.11.007 |
Ejemplares similares
-
How might tissue glucose influence responsive neurostimulation detection?
por: Wright, Kyla E., et al.
Publicado: (2019) -
Cannabis Use Frequency and Cannabis-Related Consequences in High-Risk Young Adults Across Cannabis Legalization
por: Doggett, Amanda, et al.
Publicado: (2023) -
Multiple treatment comparisons in epilepsy monotherapy trials
por: Tudur Smith, Catrin, et al.
Publicado: (2007) -
Cannabis-based treatments as an alternative remedy for epilepsy
por: Ahuja, Abhimanyu S.
Publicado: (2019) -
Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)